The Chinese government has recently included four new drug projects being developed by C&O in the major scientific and technological projects for “major new drug initiation”, the first program established by the Chinese government in the 11th Five-Year Plan specifically to encourage the development of new drugs. The goal of the program is to establish a high-end innovative drug industry in China and will provide a total of 6.6 billion yuan in funding for promising R&D projects. The project will be reviewed from dimensions including project progress, IP status, and likelihood of completion. To date, the four research projects have received funding of 7.5 million yuan.